Serum androgen bioactivity is low in children with premature adrenarche

Pediatric Research

Volumn 75, Issue 5, 2014, Pages 645-650

  Liimatta, Jani ^a   Laakso, Saila ^a   Utriainen, Pauliina ^a   Voutilainen, Raimo ^a   Palvimo, Jorma J ^a   Jääskeläinen, Tiina ^a   Jääskeläinen, Jarmo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIONE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANDROGEN BLOOD LEVEL; ANDROGEN METABOLISM; ARTICLE; BIOASSAY; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRECOCIOUS PUBERTY; PREMATURE ADRENARCHE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SENSITIVITY AND SPECIFICITY; ADOLESCENT; ADRENAL GLAND; ADRENARCHE; ADULT; ANIMAL; BLOOD; CASE CONTROL STUDY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; CROSS-SECTIONAL STUDY; METABOLISM; REPORTER GENE; YOUNG ADULT;

ADOLESCENT; ADRENAL GLANDS; ADRENARCHE; ADULT; ANDROGENS; ANIMALS; BIOLOGICAL ASSAY; CASE-CONTROL STUDIES; CERCOPITHECUS AETHIOPS; CHILD; COS CELLS; CROSS-SECTIONAL STUDIES; DIHYDROTESTOSTERONE; FEMALE; GENES, REPORTER; HUMANS; MALE; PUBERTY, PRECOCIOUS; RECEPTORS, ANDROGEN; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; YOUNG ADULT;

EID: 84899032922     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.21     Document Type: Article

References (36)

1. Dhom G. The prepuberal and puberal growth of the adrenal (adrenarche). Beitr Pathol 1973;150:357-77
2. Paterson WF, Ahmed SF, Bath L, et al. Exaggerated adrenarche in a cohort of Scottish children: Clinical features and biochemistry. Clin Endocrinol (Oxf) 2010;72:496-501
3. Utriainen P, Voutilainen R, Jääskeläinen J. Continuum of phenotypes and sympathoadrenal function in premature adrenarche. Eur J Endocrinol 2009;160:657-65
4. Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV. Steroid sulfatase: Molecular biology, regulation, and inhibition. Endocr Rev 2005;26:171-202
5. Hammer F, Subtil S, Lux P, et al. No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies. J Clin Endocrinol Metab 2005;90:3600-5
6. Chen F, Knecht K, Birzin E, et al. Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology 2005;146:4568-76
7. Brinkmann AO. Molecular mechanisms of androgen action-A historical perspective. Methods Mol Biol 2011;776:3-24
8. Chen F, Knecht K, Leu C, et al. Partial agonist/antagonist properties of androstenedione and 4-Androsten-3beta,17beta-diol. J Steroid Biochem Mol Biol 2004;91:247-57
9. Labrie F, Luu-The V, Labrie C, Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology. Front Neuroendocrinol 2001;22:185-212
10. Toda K, Simpson ER, Mendelson CR, Shizuta Y, Kilgore MW. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues. Mol Endocrinol 1994;8:210-7
11. Labrie F, Bélanger A, Simard J, Van Luu-The, Labrie C. DHEA and peripheral androgen and estrogen formation: Intracinology. Ann N Y Acad Sci 1995;774:16-28
12. Lappalainen S, Utriainen P, Kuulasmaa T, Voutilainen R, Jääskeläinen J. Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche. J Clin Endocrinol Metab 2008;93:1304-9
13. Ibáñez L, Ong KK, Mongan N, et al. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab 2003;88:3333-8
14. Petry CJ, Ong KK, Michelmore KF, et al. Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populations. J Steroid Biochem Mol Biol 2006;98:199-206
15. Petry CJ, Ong KK, Wingate DL, De Zegher F, Ibáñez L, Dunger DB. Lack of association between common polymorphisms in the 17beta- hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche. J Steroid Biochem Mol Biol 2007;105:176-80
16. Wang L, Salavaggione E, Pelleymounter L, Eckloff B, Wieben E, Weinshilboum R. Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics. J Steroid Biochem Mol Biol 2007;107:88-99
17. Hui XG, Akahira J, Suzuki T, et al. Development of the human adrenal zona reticularis: Morphometric and immunohistochemical studies from birth to adolescence. J Endocrinol 2009;203:241-52
18. Rege J, Rainey WE. The steroid metabolome of adrenarche. J Endocrinol 2012;214:133-43
19. Raivio T, Palvimo JJ, Dunkel L, Wickman S, Jänne OA. Novel assay for determination of androgen bioactivity in human serum. J Clin Endocrinol Metab 2001;86:1539-44
20. Paris F, Servant N, Térouanne B, Sultan C. Evaluation of androgenic bioactivity in human serum by recombinant cell line: Preliminary results. Mol Cell Endocrinol 2002;198:123-9
21. Rodriguez PC, Yee DJ, Sames D. Expanding the use of fluorogenic enzyme reporter substrates to imaging metabolic flux changes: The activity measurement of 5a-steroid reductase in intact mammalian cells. ACS Chem Biol 2010;5:1045-52
22. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72
23. Rosenfield RL. Normal and almost normal precocious variations in pubertal development premature pubarche and premature thelarche revisited. Horm Res 1994;41:Suppl 2:7-13
24. Vottero A, Capelletti M, Giuliodori S, et al. Decreased androgen receptor gene methylation in premature pubarche: A novel pathogenetic mechanism? J Clin Endocrinol Metab 2006;91:968-72
25. Labrie F, Luu-The V, Lin SX, et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997;62:148-58
26. Nakamura Y, Hornsby PJ, Casson P, et al. Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab 2009;94:2192-8
27. Rijk JC, Bovee TF, Peijnenburg AA, Groot MJ, Rietjens IM, Nielen MW. Bovine liver slices: A multifunctional in vitro model to study the prohormone dehydroepiandrosterone (DHEA). Toxicol In Vitro 2012; 26:1014-21
28. Hero M, Jänne OA, Näntö-Salonen K, Dunkel L, Raivio T. Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment. J Clin Endocrinol Metab 2005;90:5141-5
29. Kamrath C, Hochberg Z, Hartmann MF, Remer T, Wudy SA. Increased activation of the alternative 'backdoor' pathway in patients with 21-hydroxylase deficiency: Evidence from urinary steroid hormone analysis. J Clin Endocrinol Metab 2012;97:E367-75
30. Heinlein CA, Chang C. Androgen receptor (AR) coregulators: An overview. Endocr Rev 2002;23:175-200
31. Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymoure WJ, Kuhn RW. The serum transport of steroid hormones. Recent Prog Horm Res 1982;38:457-510
32. Todorova B, Salonen M, Jääskeläinen J, et al. Adrenocortical hormonal activity in 20-year-old subjects born small or appropriate for gestational age. Horm Res Paediatr 2012;77:298-304
33. Palvimo JJ, Reinikainen P, Ikonen T, Kallio PJ, Moilanen A, Jänne OA. Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 1996;271:24151-6
34. Adeyemo O, Kallio PJ, Palvimo JJ, Kontula K, Jänne OA. A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: The mutated receptor fails to transactivate but binds to DNA in vitro. Hum Mol Genet 1993;2:1809-12
35. Makkonen H, Jääskeläinen T, Rytinki MM, Palvimo JJ. Analysis of androgen receptor activity by reporter gene assays. Methods Mol Biol 2011;776:71-80
36. Saari A, Sankilampi U, Hannila ML, Kiviniemi V, Kesseli K, Dunkel L. New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-Age, weight-for-length/height, and body mass indexfor-Age. Ann Med 2011;43:235-48